
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

71867
10.1038/s41598-024-71867-5
Article
Clinical presentations and diagnostic approaches of pediatric necrotizing tracheobronchitis with influenza A virus and Staphylococcus aureus co-infections
Hu Chanchan
Zhang Nan
Xu Dan
Chen Zhenjie
Yu Jia
Yang Zihao hzyangzh2007@163.com

Zhang Chenmei
grid.13402.34 0000 0004 1759 700X Department of Pediatric Intensive Care Unit (PICU), Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052 China
6 9 2024
6 9 2024
2024
14 208809 1 2024
2 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
In March 2023, our pediatric intensive care unit (PICU) retrospectively examined six cases of pediatric necrotizing tracheobronchitis (NTB), focusing on co-infections with influenza A virus (IAV) and Staphylococcus aureus (S. aureus). This study aimed to elucidate NTB’s clinical characteristics, diagnostics, and therapeutic approaches. Diagnostics included symptom assessment, microbiological testing that confirmed all patients were positive for IAV H1N1 with a predominant S. aureus co-infection, and bronchoscopy. The patients predominantly exhibited fever, cough, and dyspnea. Laboratory analysis revealed decreased lymphocyte counts and elevated infection markers like C-reactive protein and procalcitonin. Chest computed tomography (CT) scans detected tracheobronchial obstructions in half of the cases, while bronchoscopy showed severe mucosal congestion, edema, necrosis, and purulent-hemorrhagic exudates. Treatments encompassed comprehensive strategies like oxygen therapy, intubation, bronchoscopic interventions, thoracentesis, oseltamivir, and a regimen of antibiotics. Our findings suggested potential correlations between clinical markers, notably lymphocyte count and procalcitonin, and clinical interventions such as the number of rescues and intensive care unit (ICU) duration. This research highlights the importance of early detection and the role of bronchoscopy and specific markers in assessing NTB, advocating for continued research in larger cohorts to better understand its clinical trajectory and refine treatment approaches for this challenging pediatric disease.

Keywords

Necrotizing tracheobronchitis
Pediatric
Influenza A virus
Staphylococcus aureus
Bronchoscopy
Subject terms

Infectious diseases
Respiratory tract diseases
Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission2022PY067 2022PY067 Hu Chanchan Yang Zihao http://dx.doi.org/10.13039/501100012166 National Key Research and Development Program of China 2021YFC2701800, 2021YFC2701801 2021YFC2701800, 2021YFC2701801 2021YFC2701800, 2021YFC2701801 2021YFC2701800, 2021YFC2701801 Xu Dan Chen Zhenjie Yang Zihao Zhang Chenmei issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Influenza A virus (IAV) continues to be a major concern in global health due to its potential for pandemics. While most IAV infections culminate in mild respiratory manifestations such as fever, cough, and sore throat, a select few evolve into grave complications, including bacterial pneumonia, myocarditis, and encephalitis. Among these, necrotizing tracheobronchitis (NTB) stands out as an infrequent but potentially fatal complication1.

NTB is characterized by tracheobronchial mucosal damage that can lead to necrosis and pseudomembrane formation, with both infectious and non-infectious origins. The sloughing of necrotic tissue and the pseudomembrane may induce acute airway obstruction, constituting a significant life hazard2–4. Clinically, NTB bears resemblances to pseudomembranous tracheobronchitis (PMTB)2. Due to its relative rarity, NTB is often reported in literature as individual case studies. Although Aspergillus is frequently identified as an etiological agent5,6, occasional reports have linked IAV7, Staphylococcus aureus (S. aureus)8, Mycoplasma pneumoniae (M. pneumoniae)3,9, and other pathogens10–12. Non-infective triggers notably involve neonatal tracheal intubation13, with sporadic associations to radiation therapy and rheumatoid arthritis14–16. To our knowledge, roughly ten NTB cases have been ascribed to concomitant IAV and S. aureus infections17–24, with half resulting in mortality. Among these, pediatric patients account for four instances17,19,24, of which three were fatal. While a significant proportion of NTB cases can be attributed to immunodeficiency9, those co-infected with IAV and S. aureus typically manifest robust immune responses. Understanding these varied causes of NTB, especially in conjunction with IAV and S. aureus infections, is crucial.

In light of the rarity and marked severity of NTB, combined with its intricate clinical implications, we amassed data from six pediatric NTB cases treated in our Pediatric Intensive Care Unit (PICU) in March 2023, each stemming from co-infections of IAV and S. aureus. With this investigation, we aspire to elucidate the clinical trajectories, findings from diagnostics, employed therapeutic regimens, and the eventual outcomes of these patients. Our ultimate goal is to bolster clinical insight, explore potential risk contributors, and highlight essential interventions that might contribute to more favorable patient outcomes.

Methods

Patients and data collection

We conducted a retrospective analysis of a cohort of six patients diagnosed with NTB who were admitted to our PICU in March 2023. Our data collection included their clinical presentations, salient findings from pathogen detection, infection markers, chest imaging, and bronchoscopic evaluations. Notably, bronchoscopy served dual purposes: it provided both diagnostic insights and therapeutic avenues. Upon clinical evaluation of airway obstruction in the PICU, bedside bronchoscopy was collaboratively performed by a multidisciplinary team, including bronchoscopists, otolaryngologists, intensive care physicians, endoscopy nurses, and critical care nurses. Under sedation, the bronchoscope was inserted through either the nasal cavity or the endotracheal tube. In cases where tracheal lumen obstruction was identified, biopsy forceps, foreign body forceps, and foreign body retrieval baskets were utilized repeatedly to remove the obstructing material. Following the removal of obstructions, saline lavage and suction were performed to clear the airway. Pathogen detection was conducted using a combination of reverse transcription polymerase chain reaction (RT-PCR) and metagenomic next-generation sequencing (mNGS) on pharyngeal swabs, sputum, and bronchoalveolar lavage fluid (BALF). RT-PCR was specifically employed to target viral ribonucleic acid (RNA), including that of IAV. mNGS facilitated a comprehensive analysis of the microbial community, enabling the identification of a broad spectrum of viral, bacterial, and fungal pathogens. Additionally, gram staining was performed on sputum and BALF samples to differentiate between gram-positive and gram-negative bacteria. These samples were cultured under aerobic and anaerobic conditions to isolate bacterial pathogens and assess their antibiotic sensitivities using standard microbiological techniques, such as susceptibility testing. Moreover, we meticulously documented the therapeutic strategies employed. These strategies spanned procedural measures, such as endotracheal intubation and closed thoracic drainage, as well as a spectrum of pharmacological treatments. We diligently recorded outcome data to gauge the efficacy and ramifications of these interventions.

Diagnostic criteria

While standardized diagnostic criteria for NTB are currently lacking, our clinical diagnoses drew heavily from the prevailing literature. This literature places emphasis on clinical presentations, microbiological findings, and endoscopic results16. Notably, some experts regard bronchoscopy as the gold standard for NTB diagnosis4. A diagnosis is corroborated when bronchoscopy unveils tracheobronchial mucosal necrosis and pseudomembrane formation. Furthermore, should a biopsy of the tracheobronchial mucosa display fibrinoid necrosis with concomitant inflammatory cell infiltration, the diagnostic assertion is further strengthened.

Statistical analysis

In our statistical evaluation, the Shapiro–Wilk test was first employed to assess the normality of data distribution. Given the constrained sample size and potential outliers, we presented descriptive statistics as medians (M), accompanied by the first (Q1) and third (Q3) quartiles, represented as M (Q1-Q3). To identify differences in infection markers before and after treatment, we utilized the Wilcoxon signed-rank test, with p-values adjusted for multiple comparisons using the false discovery rate (FDR). The paired Vargha-Delaney A values further aided in discerning the magnitude of group differences. Because some data did not follow a normal distribution, we systematically employed the Spearman rank correlation test for correlation analyses. For approximating confidence intervals for the Spearman coefficient, we used Fisher’s Z transformation25.Our regression analysis began with univariate linear regression due to the constraints of the dataset. Potential nonlinearities led us to consider polynomial regression. When faced with outliers or high leverage points, we resorted to robust linear regression. For the count variable ‘number of rescues (NumRescues)’, our initial analysis using negative binomial regression resulted in statistically non-significant coefficients. Given this result, we addressed zero counts by incrementing them by one, then applied a logarithmic transformation, and subsequently used linear regression. To ensure the robustness of the regression model, we verified major assumptions through residual plots, quantile–quantile (QQ) plots, and various statistical tests, including the Shapiro–Wilk, Jarque–Bera, Durbin–Watson, and Levene’s test. A two-tailed p-value less than 0.05 indicated statistical significance. All analytical procedures were performed in a Python 3.8 environment, leveraging libraries such as pandas (1.2.3), numpy (1.19.2), scipy (1.6.1), statsmodels (0.12.2), matplotlib (3.3.4), and seaborn (0.11.1).

Ethical approval

This study was approved by the Medical Ethics Committee of Children’s Hospital, Zhejiang University School of Medicine, documented under Approval Number 2023-IRB-0241-P-01. All methods were carried out in accordance with the Declaration of Helsinki and other relevant guidelines and regulations. Written informed consent was obtained from the parents of the children included in this study for participation and publication of identifiable details and accompanying images. Copies of the written consents are available for review by the Editor of this journal.

Results

Patient characteristics

Among the six patients, the median age was 9Y2M (6Y1M-9Y7M). The cohort included four males and two females, with males comprising two-thirds. The median body weight (BW) was 28.0 kg (20.8–31.1 kg). All patients were previously healthy, with no reported history of immunodeficiency disorders or recurrent infections. Detailed clinical data for each patient are provided in Table 1.Table 1 Patient characteristics and infection markers upon admission.

Case	Age	Sex	BW (kg)	Chief complaint	WBC (× 109/L)	LC (× 109/L)	CRP (mg/L)	PCT (ng/mL)	IL-6 (pg/mL)	IL-10 (pg/mL)	
1	1Y11M	Female	11.5	Fever for 5 days, cough, hoarseness, and dyspnea for 3 days	4.84	0.84	137.86	37.31	172.1	21.7	
2	9Y5M	Male	28.5	Fever for 3 days, difficulty breathing for 2 days	6.34	0.43	290.97	13.29	224.1	23.5	
3	8Y11M	Male	36.0	Fever with cough for 2 days	8.18	0.63	125.12	4.09	14.0	12.7	
4	9Y10M	Male	32.0	Fever with sore throat for 2 days, chest pain for 1 day	8.02	0.35	287.67	33.40	1425.1	15.5	
5	5Y2M	Male	18.6	Fever with dyspnea for 1 day	24.06	0.36	112.99	16.20	637.6	154.1	
6	9Y8M	Female	27.4	Fever for 4 days, cough for 2 days	13.09	1.15	28.64	9.73	12.4	7.5	
BW body weight, WBC white blood cell count, LC lymphocyte count, CRP C-reactive protein, PCT procalcitonin, IL-6 interleukin-6, IL-10 interleukin-10.

Pre-admission status

Patients were admitted a median of 2.5 days (2.0–3.8 days) post symptom onset. Two had previously been hospitalized at different institutions for durations of 2 and 4 days, respectively. From the onset of illness, fever was observed in all patients. Furthermore, in addition to this universal symptom, two patients predominantly displayed coughs, three experienced shortness of breath, and one described chest pain. All patients denied any history of foreign body aspiration. Clinical data for each patient are detailed in Table 1.

Clinical status upon admission

Vital signs were recorded as follows: the median temperature (T) was 38.4 °C (38.1–38.5 °C); the median pulse rate (PR) was 155 bpm (131–169 bpm); the median respiratory rate (RR) was 47 bpm (43–48 bpm); and blood pressure (BP) measurements showed a median of 109/76 mmHg (systolic: 104–110 mmHg, diastolic: 71–78 mmHg). The peripheral oxygen saturation (SpO2) was determined to be 96% (95–97%). Upon their arrival, all patients required oxygen support: one utilized a nasal cannula, four made use of face masks, and one was intubated. During physical examinations, tachypnea and visible retractions were evident in all patients. For one patient, breath sounds were distinctly reduced on the right side, three presented with moist rales, while the remaining two showed no signs of either dry or moist rales. Comprehensive immunological assessments included measurements of immunoglobulins and complement components, with values within normal ranges: IgG 8.41 g/L (7.79–10.89 g/L), IgA 1.39 g/L (1.12–1.67 g/L), IgM 0.80 g/L (0.57–0.97 g/L), C3 1.13 g/L (0.97–1.28 g/L), C4 0.33 g/L (0.24–0.44 g/L), and IgE 110.9 IU/mL (23.2–282.0 IU/mL). Cellular profiles revealed variations, with CD19 at 37.80% (36.00–39.00%), CD3 at 36.89% (34.50–42.72%), CD4 at 17.77% (17.30–20.33%), CD8 at 13.77% (10.35–18.60%), and CD3−CD16+CD56+ at 6.60% (5.75 − 17.00%). Despite these variations, no evidence of underlying immunodeficiencies was found.

Evaluation of infection markers

During hospitalization, we assessed several infection markers in patients, including white blood cell count (WBC), lymphocyte count (LC), C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and interleukin-10 (IL-10). Here, “Init” refers to initial values upon admission; “Max” to peak values; “Min” to the lowest recorded values; and “Final” to values from the last examination before discharge. Initial infection markers upon admission are detailed in Table 1.

For WBC, initial analyses revealed significant differences between InitWBC and MinWBC, as well as between MinWBC and MaxWBC (p < 0.05, Fig. 1a). However, these distinctions were not significant after FDR adjustment. Effect size analysis showed an A value of 1.00 between InitWBC and MinWBC and an A value of 0 for the comparison of MinWBC and MaxWBC. Concerning LC, all comparisons exhibited significant differences (p < 0.05, Fig. 1b), except for the MaxLC versus FinalLC comparison. Post FDR correction, the difference between InitLC and MinLC was no longer significant, but other comparisons maintained their significance (p < 0.05). Effect size yielded an A value of 0.92 for InitLC versus MinLC and an A value of 0 for both comparisons involving InitLC and MinLC against MaxLC and FinalLC.Fig. 1 Dynamics of in-hospital infection markers and their correlations. (a) Variations in WBC. No significant differences were observed after FDR adjustment. (b) Fluctuations in LC with marked significant differences (*p < 0.05). (c) Changes in CRP levels (*p < 0.05). (d) Alterations in PCT levels (*p < 0.05). (e) IL-6 levels during hospital stay. No significant differences were observed after FDR adjustment. (f) IL-10 levels, with significant differences marked (*p < 0.05). (g) Spearman correlation between InitLC and other initial infection markers (**p < 0.01). (h) Spearman correlation of MinLC with peak and trough infection marker values (*p < 0.05).

For CRP, significant differences emerged between InitCRP and FinalCRP, and between MaxCRP and FinalCRP (corrected p < 0.05, A = 1.00, Fig. 1c). PCT showcased significant variances between InitPCT and FinalPCT, and between MaxPCT and FinalPCT (corrected p < 0.05, A = 1.00, Fig. 1d). With IL-6, a significant initial difference was noted between MaxIL-6 and FinalIL-6, which turned non-significant after FDR correction. Importantly, the effect size, as denoted by the A value, was 1.00 (Fig. 1e). For IL-10, marked differences were detected between InitIL-10 and FinalIL-10, and between MaxIL-10 and FinalIL-10 (corrected p < 0.05, A = 1.00, Fig. 1f).

Correlation analyses underscored a strong negative correlation between InitLC and InitIL-6 (ρ =  − 0.94, p = 0.005, Fig. 1g). MinLC negatively correlated with both MaxIL-6 and MaxIL-10 (ρ =  − 0.89, p = 0.019, Fig. 1h). Additionally, a substantial positive correlation existed between MaxIL-6 and MaxIL-10 (ρ = 0.89, p = 0.019).

Microbiological findings

Of the six patients evaluated, four tested positive for IAV H1N1 within the first 2 days of admission using pharyngeal swab, sputum, or BALF analyses via either RT-PCR or mNGS. Additionally, mNGS evaluations of BALFs diagnosed the other two patients with IAV H1N1 on the fourth day post-admission.

Upon admission, Gram-positive cocci (G+ cocci) were detected in the sputum smear or BALF smear of two patients. Between the third and sixth days post-admission, five patients tested positive for S. aureus through sputum culture, BALF culture, or mNGS. Among them, four were confirmed to have Methicillin-sensitive S. aureus (MSSA), and one was identified with Methicillin-resistant S. aureus (MRSA).

Additionally, M. pneumoniae and Haemophilus influenzae (H. influenzae) were identified in the BALF of one patient through mNGS. In another patient, although elevated M. pneumoniae IgM antibodies were observed, M. pneumoniae nucleic acids were absent in respiratory specimens. However, adenovirus nucleic acids were positively identified in the BALF via polymerase chain reaction (PCR) analysis. Detailed microbiological distributions can be found in Table 2.Table 2 Initial diagnostic findings and pathological results.

Case	Pathogen	Initial chest CT results	Initial bronchoscopy results	Pathological results	
1	IAV H1N1, S. aureus	Infectious lesions were present in both lungs, with possible tracheal secretions. Narrowing and occlusion were observed in the right middle and lower lobes and the left lower lobe basal bronchus, along with a small amount of right pleural effusion	The trachea was filled with purulent and bloody secretions. Multiple attempts with foreign body forceps successfully removed large amounts of pseudomembranous necrotic tissue and molded mucous plugs. Post-clearing, significant congestion, edema, erosion, and necrosis of the tracheal and bronchial mucosa were observed, along with large amounts of purulent secretions	(Airway) microscopy showed extensive necrosis with infiltration of lymphocytes, plasma cells, neutrophils, and histiocytes	
2	IAV H1N1, S. aureus	Obstructive inflammation caused by mucous plugs was observed in the trachea, right middle lobe, and lower lobe bronchi, leading to segmental atelectasis. Additionally, a small amount of bilateral pleural effusion was noted	Large amounts of purulent and bloody secretions blocked the trachea and main bronchi. Multiple pseudomembranous necrotic tissues and molded mucous plugs were removed using biopsy forceps and a foreign body retrieval basket. Post-clearing, the main bronchi mucosa showed congestion, edema, significant erosion, and necrosis, with pseudomembranous necrotic tissues in distal airways	(Bronchus) fibrinoid necrosis, exudates with inflammatory cell infiltration	
3	IAV H1N1, S. aureus, M. pneumoniae, H. influenzae	Pneumonia with consolidation and atelectasis was noted in the right middle lobe and left lower lobe segments, accompanied by a small left pleural effusion and a high-density shadow in the lower trachea	The larynx showed mucosal congestion and swelling, with erosion and exudation in the vocal cords and subglottic mucosa. The trachea and bronchi had mucosal congestion and erosion, with white pseudomembranous materials attached. Large amounts of yellow viscous secretions and purulent mucous plugs were washed out with saline	Not sent for examination	
4	IAV H1N1, S. aureus	Multiple infectious lesions were detected in both lungs	The pharynx, trachea, and main bronchi showed mucosal erosion and necrosis, significant congestion and edema, with white pseudomembranous materials attached. The mucosa was prone to bleeding, and large amounts of purulent secretions and mucous plugs were washed out with saline	(Bronchial biopsy) fibrinoid necrosis, exudates with inflammatory cell infiltration	
5	IAV H1N1, G+ cocci	Pneumonia with localized consolidation was present in the right lung, along with pleural effusion	Large amounts of purulent and bloody secretions blocked the trachea and main bronchi. Biopsy forceps removed multiple pseudomembranous necrotic tissues and molded mucous plugs, and large amounts of yellow purulent mucous plugs were washed out with saline. The main bronchi mucosa showed congestion, edema, significant erosion, and necrosis, with pseudomembranous materials attached	Not sent for examination	
6	IAV H1N1, S. aureus, Adenovirus, M. pneumoniae	Multiple lung infections were observed, with localized consolidation	The right supraglottic mucosa showed erosion and necrosis, with extensive mucosal erosion and necrosis throughout the airway. There was significant congestion and edema, with white pseudomembranous materials attached and mucosa prone to bleeding. Moderate amounts of purulent secretions and mucous plugs were washed out with saline	Not sent for examination	
CT computed tomography, IAV H1N1 influenza A virus H1N1, S. aureus Staphylococcus aureus, M. pneumoniae Mycoplasma pneumoniae, H. influenzae Haemophilus influenzae, G+ cocci gram-positive cocci.

Radiological findings

Within the first three days after the emergence of symptoms, chest computed tomography (CT) imaging for the six patients demonstrated marked infectious changes within the lung parenchyma. The majority presented with lung consolidation and pleural effusion. Notably, three patients had evidence of tracheobronchial obstruction, resulting in bronchial narrowing and atelectasis (Fig. 2a). Detailed information can be found in Table 2.Fig. 2 Evolution of chest CT findings across disease progression. (a) Early-stage chest CT reveals a foreign object within the trachea; (b) Mid-course chest CT displays signs of pneumonia and pneumothorax; (c) Convalescent-stage chest CT shows improvement in both pneumonia and pneumothorax, with the presence of a pulmonary cavity.

As the days advanced, especially between days 5 and 15, the radiological manifestations of pneumonia intensified across all patients. A majority, four out of six, presented with atelectasis and lung consolidation. Concurrently, conditions such as pneumothorax or subcutaneous emphysema emerged in five patients, with pleural effusion also being a prominent finding in the same number of individuals (Fig. 2b).

In the later stages of the disease, predominantly after two weeks, all patients demonstrated an improvement in pulmonary inflammatory changes compared to earlier stages. Instances of pneumothorax, subcutaneous emphysema, and pleural effusion also started to resolve. However, one patient developed a new pulmonary cavity, and another exhibited a more pronounced local bronchiectasis compared to earlier imaging findings (Fig. 2c).

Bronchoscopic observations and procedures

Upon hospitalization, bronchoscopic evaluations were conducted for all patients. The primary examination displayed marked congestion, edema, and necrotic erosion across the tracheal and bronchial mucosa. A delicate white pseudomembrane, prone to bleeding upon contact, was discerned. The airways were predominantly filled with purulent-hemorrhagic secretions. Notably, the trachea of three patients was obstructed by abundant purulent-hemorrhagic materials. Using bronchoscopic instruments, substantial pseudomembranous fragments and cast-like sputum were extracted. Saline lavage was then administered to cleanse the mucoid and purulent secretions. Additionally, mucosal erosions and necrosis were apparent in the pharynx of three patients (Fig. 3a). Detailed bronchoscopic findings are provided in Table 2.Fig. 3 Bronchoscopic evaluation of airway mucosal damage and recovery. (a) Initial bronchoscopy showing erosion of the pharyngeal mucosa, necrotic formations within the trachea, and the presence of a pseudomembrane in the left main bronchus. (b) Intermediate stage bronchoscopy revealing continued congestion and edema in the pharyngeal mucosa, mucosal erosion at the tracheal carina, and a mucus plug observed at the left second carina. (c) Recovery stage bronchoscopy indicating improved mucosal erosion in the glottal region, persistent congestion at the tracheal carina, and a notable reduction in the edema of the left upper bronchial mucosa.

A subsequent assessment after 5–7 days revealed persistent mucosal congestion and edema in the cohort. Some demonstrated recovery in areas that were previously eroded or necrotic. The airways mainly housed yellow viscous or purulent secretions, and a sputum plug was identified in one patient (Fig. 3b).

During the convalescence period, bronchoscopic evaluations showcased patent airways across all patients. Although mucosal congestion persisted, the earlier observed necrotic regions and erosions exhibited marked healing. The airways predominantly held yellow or white viscous secretions. In some instances, mucoid plugs were detected, which were subsequently lavaged (Fig. 3c).

Histopathological examinations of bronchial biopsies

During the bronchoscopic procedure, biopsies were obtained from three distinct patients. Subsequent histopathological evaluations consistently revealed fibrinoid necrosis in bronchial tissues, accompanied by exudative changes and significant inflammatory cell infiltration (refer to Fig. 4). Detailed histopathological findings are provided in Table 2.Fig. 4 Histopathological examinations of a consistent bronchial site visualized at varying magnifications, using hematoxylin and eosin (H&E) staining technique. Fibrinoid necrosis is denoted by the black arrows, while the red arrows indicate the regions of inflammatory cell infiltration.

Treatment

Upon admission, all six patients required supplemental oxygen. Two exhibited milder symptoms and did not necessitate tracheal intubation. One patient was emergently intubated outside the hospital setting, and the remaining three were intubated within the first 1–2 days after admission. During their hospital stay, each of the four intubated patients underwent 1–3 emergency interventions. These included six instances related to airway obstructions due to endogenous foreign bodies, two due to pneumothorax, and one episode of septic shock resulting from a severe infection.

All patients underwent bronchoscopic examinations, lavage, and foreign body removal within a median timeframe of 1.0 (1.0–1.8) days following admission. Following these procedures, five patients received thoracentesis and closed thoracic drainage. Notably, drainage persisted for 40 days in one patient due to an unresolved pneumothorax.

Upon diagnosing IAV infection, oseltamivir was immediately prescribed to all patients. Given the potential risk of severe bacterial co-infections, broad-spectrum antibiotics were initiated early in the treatment course. Additionally, either vancomycin or linezolid was employed to address Gram-positive bacterial infections. Two patients, diagnosed with concurrent M. pneumoniae infection, were additionally treated with azithromycin. All patients received methylprednisolone to counteract inflammation, with four also undergoing intravenous immunoglobulin (IVIG) therapy.

A detailed summary of critical clinical procedures, their timings, durations, and frequencies post-onset, is provided in Fig. 5. Specific treatment interventions for each patient are detailed in Table 3.Fig. 5 Clinical intervention timelines and treatment durations post-disease onset. (a) Median days post-onset for various clinical interventions, including days from onset to admission (DOTA), time to intubation (IntubationTime), initial rescue time (InitRescueTime), initial bronchoscopy time (InitBronchTime), initial thoracentesis time (InitThoracentesisTime), and initial closed thoracic drainage time (InitCTDrainageTime). The error bars indicate the interquartile range (IQR).(b) A box plot illustrating the duration (in days) of various clinical stages and procedures: Duration of Hospital Stay (DurHospStay), duration of intensive care unit (ICU) Stay (DurICUStay), oxygen therapy duration (OxygenTherapyDur), duration of mechanical ventilation (MechVentDur), and duration of closed thoracic drainage (DurCTDrainage).(c) Median frequencies of specific clinical procedures post-onset: NumRescues, number of bronchoscopies (NumBronchoscopies), number of thoracentesis procedures (NumThoracentesis), and number of closed thoracic drainage procedures (NumCTDrainage). The error bars represent the IQR.

Table 3 Interventions, medication treatments, and outcomes.

Case	Interventions	Medication treatment	Outcome	
1	Tracheal intubation with ventilator support, bronchoscopy, cardiopulmonary resuscitation, thoracentesis and closed thoracic drainage	Oseltamivir, meropenem, vancomycin, linezolid, methylprednisolone, IVIG	Transferred for rehabilitation treatment	
2	Tracheal intubation with ventilator support, bronchoscopy, thoracentesis and closed thoracic drainage	Oseltamivir, piperacillin/tazobactam, vancomycin, linezolid, methylprednisolone, IVIG	Recovered and discharged	
3	Oxygen mask, bronchoscopy	Oseltamivir, azithromycin, cefoperazone/sulbactam, linezolid, methylprednisolone	Recovered and discharged	
4	Tracheal intubation with ventilator support, bronchoscopy, cardiopulmonary resuscitation, thoracentesis and closed thoracic drainage	Oseltamivir, meropenem, linezolid, methylprednisolone, IVIG	Recovered and discharged	
5	Tracheal intubation with ventilator support, bronchoscopy, thoracentesis and closed thoracic drainage	Oseltamivir, meropenem, vancomycin, methylprednisolone, IVIG	Recovered and discharged	
6	Oxygen mask, bronchoscopy, thoracentesis and closed thoracic drainage	Oseltamivir, azithromycin, ceftriaxone, linezolid, methylprednisolone	Recovered and discharged	
IVIG intravenous immunoglobulin.

Clinical outcomes

Among the six patients, one encountered an airway obstruction attributed to an endogenous foreign body. This patient required multiple cardiopulmonary resuscitation interventions, subsequently developing neurological impairment. Upon achieving clinical stability, the individual was transferred to a rehabilitation facility. Conversely, the remaining five patients experienced a successful discharge, exhibiting a favorable post-treatment recovery. Detailed outcomes for each patient are provided in Table 3.

Correlation and regression analysis

In our comprehensive analysis, we explored correlations among various biophysical markers and clinical parameters, with a particular focus on emergency interventions, mechanical ventilation duration, and hospital stay duration. The Spearman correlation revealed significant associations of InitPCT, MinLC, NumThoracentesis, and PR with NumRescues. However, these associations were not confirmed when assessed using negative binomial regression. After log-transforming NumRescues and applying linear regression, a notable association emerged between MinLC and the transformed NumRescues (β =  − 3.31, p = 0.012, R2 = 0.829, Fig. 6a).Fig. 6 Correlation and regression analyses of biophysical markers, clinical interventions and patient outcome measures. (a) Linear regression of MinLC vs. log-transformed NumRescues. (b) Univariate regressions of PR, InitPCT, and NumRescues with MechVentDur. (c) Univariate regressions of InitPCT, NumBronchoscopies, NumRescues, and MechVentDur with DurICUStay. (d) Linear regression of DurCTDrainage vs. OxygenTherapyDur. (e) Quadratic polynomial and robust regressions of MaxWBC vs. DurHospStay.

Significant linear relationships were discerned between PR, InitPCT, NumRescues, and MechVentDur. The respective coefficients for MechVentDur were as follows: PR (β = 0.11, p = 0.013, R2 = 0.818), InitPCT (β = 0.25, p = 0.038, R2 = 0.698), and NumRescues (β = 2.63, p = 0.013, R2 = 0.822), visualized in Fig. 6b. Associations between InitPCT, NumBronchoscopies, NumRescues, and MechVentDur with DurICUStay were also observed. The linear regression coefficients for these associations included: InitPCT (β = 0.28, p = 0.003, R2 = 0.912), NumBronchoscopies (β = 1.41, p = 0.016, R2 = 0.803), NumRescues (β = 2.58, p = 0.016, R2 = 0.802), and MechVentDur (β = 0.86, p = 0.025, R2 = 0.755), depicted in Fig. 6c. A significant correlation between DurCTDrainage and OxygenTherapyDur was also evident (β = 0.87, p < 0.001, R2 = 0.998, Fig. 6d).

While MaxWBC showed a positive correlation with DurHospStay (ρ = 0.94, p = 0.005), it was not statistically significant in the linear regression (R2 = 0.599, p = 0.071). A quadratic polynomial regression, however, indicated a nuanced nonlinear relationship (R2 = 0.893, p = 0.035). Data diagnostics pinpointed two high-leverage points, which were supported by a robust linear regression presenting significant quadratic terms (constant β₀ = 20.92, p = 0.006; linear term β₁ = -1.21, p = 0.110; quadratic term β₂ = 0.05, p = 0.006, Fig. 6e). Based on the parameters derived from the robust linear regression with higher precision coefficients (not shown), an inflection point at a MaxWBC value of 13.16 × 109/L was mathematically determined, signifying a critical threshold where the relationship between MaxWBC and DurHospStay alters.

In assessing our regression models, the majority of the assumptions were upheld. The Shapiro–Wilk test identified deviations in residuals’ normality for the models linking NumRescues to MechVentDur and NumBronchoscopies to DurICUStay. Nevertheless, subsequent validations using the Jarque–Bera test and graphical analyses confirmed the overall normality of residuals. These observed discrepancies may be attributed to our constrained sample size.

Discussion

During the 2023 influenza season, we examined six pediatric NTB cases linked to IAV and S. aureus. These children primarily manifested fever, cough, and dyspnea, concurrent with a reduction in LC and elevations in CRP, PCT, IL-6, and IL-10. Influenza was promptly diagnosed through RT-PCR or mNGS of respiratory samples, while bacterial involvement was confirmed via smears, cultures, and mNGS. Initial chest CT may reveal potential airway obstructions, with bronchoscopy confirming tracheal mucosal necrosis. The rapidity of disease progression and significant risk of airway obstruction underscore the imperative of early intervention. Essential treatments encompassed oxygen therapy, mechanical ventilation, bronchoscopic procedures, thoracic drainage, and timely initiation of antivirals, antibiotics, and corticosteroids. Moreover, we observed potential correlations between initial PR and PCT with mechanical ventilation duration. The nadir LC appeared to be inversely associated with the frequency of emergency interventions, and peak WBC exhibited a non-linear relationship with the length of hospitalization, initially negative, then becoming positive. Other vital clinical parameters, including the frequency of emergency interventions, number of bronchoscopies, and duration of closed thoracic drainage, seemed to be associated with variations in mechanical ventilation, ICU stays, and oxygen therapy durations.

The pathogenesis of this condition remains incompletely understood, but it is potentially associated with the synergistic interplay between IAV and S. aureus. IAV predominantly replicates within the airway and alveolar epithelial cells, leading to cellular damage and a compromise of barrier integrity, which in turn elicits extensive immune cell infiltration. Owing to the degradation of this epithelial barrier and altered immune defenses, secondary bacterial infections become more prevalent, with Streptococcus pneumoniae and S. aureus standing out as primary culprits26. Notably, strains of S. aureus, especially those producing Panton–Valentine leukocidin (PVL), exhibit a specific affinity for the exposed basement membrane following epithelial shedding. The released PVL targets and disrupts newly recruited polymorphonuclear leukocytes, resulting in the liberation of inflammatory mediators. In the context of an IAV infection, the phagocytic capacity of alveolar macrophages diminishes, permitting unhindered bacterial proliferation. This combined action of IAV and S. aureus results in severe tracheobronchial and pulmonary lesions, manifesting as NTB and necrotizing pneumonia23,27.

Recognizing early clinical manifestations of NTB is pivotal for accurate diagnosis and timely intervention. In our cohort, the six observed patients predominantly fell within the school-aged bracket. While the literature primarily reports pediatric NTB cases between ages 7 and 9 years17,19, it also highlights occurrences in younger children, particularly between 1 and 3 years24. Our observations confirm this trend and extend to cases in children aged 1Y11M and 5Y2M. This suggests that, although NTB primarily affects school-aged children, it can also present in younger age groups. However, our study’s limited sample size may restrict the generalizability of these findings to the broader NTB population. NTB co-infected by IAV and S. aureus initially presents with influenza-like symptoms, occasionally accompanied by dyspnea and chest pain. Some patients may also experience hoarseness if the larynx is involved. As it evolves, airway obstruction becomes prevalent, mirroring most case narratives17,19,24. Early in the disease trajectory, we detected a pronounced elevation in infection-related markers, namely CRP, PCT, IL-6, and IL-10. These findings are consistent with previous research indicating the utility of these biomarkers in diagnosing bacterial infections, particularly those involving the bloodstream28. Notably, elevated levels of IL-6 and IL-10 have been identified as reliable indicators of disease severity in pediatric patients with sepsis in ICU29. The early detection of these elevated markers in our patients suggests the presence of a severe bacterial infection. Although WBC levels may appear normal or slightly reduced, there’s a marked decline in LC, corroborating previous studies30. Expedient etiological identification is of the essence. Respiratory assays, encompassing influenza antigens, RT-PCR, and mNGS, bolster early IAV discernment. Even though pinpointing bacterial origins early on poses challenges, smear tests swiftly discern G+ cocci, and mNGS heightens diagnostic precision. Bacterial culture, nonetheless, remains instrumental for tailoring antibiotic regimens. In our cases, initial chest CTs for three patients revealed tracheal and bronchial opacities suggestive of foreign bodies. Yet, a majority in existing literature display merely pulmonary inflammatory alterations in early scans, with a scant few indicating bronchial wall thickening or foreign shadows18,24. This hints at the circumscribed diagnostic potential of early chest CTs. A conclusive diagnosis predominantly hinges on bronchoscopy, a consensus echoed across numerous case reports17,19,24. Conclusively, while NTB’s onset might mimic severe influenza, a notable surge in infectious markers often suggests an ensuing bacterial superinfection. Accurate early etiological discernment, especially if bronchial anomalies are evident on initial CTs, warrants immediate bronchoscopic evaluation and robust intervention, preempting potential airway obstructions.

Exploring factors linked to disease severity can offer insights, though interpretations must be approached with caution due to our study’s small sample size. We investigated correlations between initial clinical presentations, laboratory results, essential clinical interventions and the severity spectrum of the disease. Our analysis observed a notable negative association between MinLC and NumRescues, suggesting that lower LC levels may necessitate more frequent medical interventions. This association, supported by log-transformed linear regression, underscores the need for cautious interpretation due to the small sample size. A study indicates that severe influenza infections correlate with significant reductions in LC30. Aligning with these findings, recent studies have shown that reductions in specific lymphocyte subsets, notably T cells and Natural Killer cells (NK cells), correlate with increased disease severity in respiratory infections like coronavirus disease 2019 (COVID-19) and influenza, highlighting their role in prognosis and treatment planning31,32. Furthermore, influenza infections have been shown to suppress Th17 and γδ T cell functions and potentially inhibit NK cell responses, reducing the production of tumor necrosis factor (TNF) and consequently increasing bacterial burden33. This is consistent with the cellular immune findings in our six patients, all of whom showed decreased proportions of T cells and NK cells upon admission. This result aligns with a recent case of an adult with influenza B and S. aureus co-infection leading to NTB34. Additionally, we observed significant negative correlations between InitLC and InitIL-6, as well as between MinLC and MaxIL-6 and MaxIL-10, suggesting intricate interactions between decreased LC and increased cytokine release. Research on COVID-19 has suggested that early CD3+ T cell counts and IL-6 levels may serve as predictive markers for severe disease progression in viral infections35,36, raising the possibility that similar markers could be relevant in our study of influenza infections, warranting further investigation. These preliminary findings underscore the necessity for larger, more definitive studies to confirm these potential associations and further elucidate the role of lymphocytes and cytokines in the progression of severe respiratory infections.

In evaluating NTB severity, we explored associations with MechVentDur and DurICUStay, finding a notable positive correlation between InitPCT and both variables. Furthermore, a potent positive relationship between MechVentDur and DurICUStay hinted at potential collinearity, which warrants careful scrutiny. Elevated initial PCT levels might serve as an early indication of an impending bacterial infection37,38, which could necessitate extended durations of mechanical ventilation and ICU stays. A significant relationship was observed between PR and MechVentDur. Given the variability of PR across different pediatric age groups, and acknowledging that the patient ages in our study ranged predominantly from 6Y1M to 9Y7M, PR at admission might tentatively correlate with initial disease severity. Clinically, severe infections in children are commonly associated with increased heart rates39–41. Additionally, a nuanced nonlinear relationship was revealed between MaxWBC and the duration of hospital stay: an initial shortening in stay duration with an increase in MaxWBC, followed by an elongation upon exceeding the 13.16 × 109/L threshold. This pattern could reflect the sequence of an initial IAV infection with normalized or reduced WBC, followed by a subsequent S. aureus infection increasing the WBC count. Prior studies suggest that higher WBC counts may be associated with increased severity of infections such as COVID-19 and sepsis, indicating their potential value in predicting patient outcomes42,43. These observations reveal the possible role of WBC counts in monitoring and managing severe infectious diseases.

From an interventional standpoint, notable associations were observed between NumRescues and both MechVentDur and DurICUStay, between NumBronchoscopies and DurICUStay, and between DurCTDrainage and OxygenTherapyDur. Increased rescue events may indicate heightened disease severity, potentially correlating with longer durations of mechanical ventilation and ICU stays. The frequency of bronchoscopies might act as an indicator of the extent of airway mucosal damage; significant damage may necessitate more frequent bronchoscopic interventions to mitigate respiratory obstructions, potentially leading to prolonged ICU stays. Notably, in the six patients discussed, pneumothorax was the primary reason for continuous closed thoracic drainage. Given that oxygen therapy is a primary intervention for pneumothorax44, its synchronization with DurCTDrainage is consistent with established clinical guidelines. Our study contributes to understanding how these clinical interventions may influence the course of the disease.

Our investigation included six cases of NTB. Within this group, G+ cocci were observed on a smear in one patient, but culturing for S. aureus was unsuccessful; two additional cases were marked by concurrent pathogen infections. These variations in etiology underscore the importance of meticulous clinical evaluation, which influences the interpretation of infectious markers and the strategic planning of treatment regimens. The study’s retrospective design inherently carries limitations such as the absence of a randomized control group and the potential for confounding factors. The rarity of NTB further constrained our sample size. While correlation and regression analyses were utilized to examine significant biomarkers, therapeutic interventions, and treatment progressions, the small cohort size limited the application of complex multivariate regression, thereby restraining a comprehensive analysis of the relationships between variables. Our statistical results suggest associations between specific biomarkers and disease progression, yet they should be interpreted with caution and not be construed as confirmation of causality. Future research efforts should aim to increase sample sizes to enhance the understanding of NTB and its clinical markers, thereby better informing clinical practice.

Conclusion

In conclusion, this study explores the clinical manifestations, diagnostic methods, and treatment measures of pediatric NTB caused by co-infections of IAV and S. aureus. Our findings underscore the importance of early detection, through advanced diagnostic modalities and timely intervention to mitigate severe complications of NTB. Factors such as diminished LC and elevated infection markers were examined as potential indicators of disease severity. Although the limited sample size warrants cautious interpretation, our study provides a foundation for understanding the clinical course of NTB. Continued investigations with larger cohorts are essential to further elucidate this condition and optimize therapeutic strategies for pediatric populations.

Author contributions

Study conception and design: ZH Yang, CC Hu, CM Zhang. Acquisition of data: CC Hu, N Zhang, D Xu. Analysis and interpretation of data: CC Hu, ZJ Chen, J Yu. Drafting of the manuscript: CC Hu. Critical revision: ZH Yang, CM Zhang. All authors have read and approved the final manuscript.

Funding

This work was supported by the National Key Research and Development Program of China (Grant Numbers: 2021YFC2701800, 2021YFC2701801), and the Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission (Grant Number: 2022PY067).

Data availability

Data will be made available from the corresponding author on reasonable request.

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Paules C Subbarao K Influenza Lancet 2017 390 697 708 10.1016/S0140-6736(17)30129-0 28302313
Paules, C. & Subbarao, K. Influenza. Lancet 390, 697–708 (2017).28302313 10.1016/S0140-6736(17)30129-0
2. Kawakami N Pseudomembranous tracheobronchitis with severe tracheal stenosis and masked bronchial obstruction J. Emerg. Med. 2021 60 e39 e44 10.1016/j.jemermed.2020.10.041 33353810
Kawakami, N. et al. Pseudomembranous tracheobronchitis with severe tracheal stenosis and masked bronchial obstruction. J. Emerg. Med. 60, e39–e44 (2021).33353810 10.1016/j.jemermed.2020.10.041
3. Lei W Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: A case report and literature review BMC Infect. Dis. 2022 22 183 10.1186/s12879-022-07160-5 35197010
Lei, W. et al. Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: A case report and literature review. BMC Infect. Dis. 22, 183 (2022).35197010 10.1186/s12879-022-07160-5
4. Wen S-H Pseudomembranous laryngotracheobronchitis due to coinfection with human bocavirus 1 and Mycoplasma pneumoniae: A case report Transl. Pediatr. 2021 10 673 678 10.21037/tp-20-278 33880337
Wen, S.-H. et al. Pseudomembranous laryngotracheobronchitis due to coinfection with human bocavirus 1 and Mycoplasma pneumoniae: A case report. Transl. Pediatr. 10, 673–678 (2021).33880337 10.21037/tp-20-278
5. Fernández-Ruiz M Aspergillus tracheobronchitis: Report of 8 cases and review of the literature Medicine 2012 91 261 10.1097/MD.0b013e31826c2ccf 22932790
Fernández-Ruiz, M. et al. Aspergillus tracheobronchitis: Report of 8 cases and review of the literature. Medicine 91, 261 (2012).22932790 10.1097/MD.0b013e31826c2ccf
6. Cho JS Kim JJ Jeong SY Soo Lee Y Kim M Park SJ Koh MJ Pseudomembranous aspergillus tracheobronchitis: Case report of a rare manifestation of airway invasive aspergillosis Taehan Yongsang Uihakhoe Chi 2022 83 737 743 36238520
Cho, J. S. et al. Pseudomembranous aspergillus tracheobronchitis: Case report of a rare manifestation of airway invasive aspergillosis. Taehan Yongsang Uihakhoe Chi 83, 737–743 (2022).36238520
7. Chang J Necrotizing tracheobronchitis causing airway obstruction complicated by pandemic 2009 H1N1 influenza Medicine 2020 99 e18647 10.1097/MD.0000000000018647 31895828
Chang, J. et al. Necrotizing tracheobronchitis causing airway obstruction complicated by pandemic 2009 H1N1 influenza. Medicine 99, e18647 (2020).31895828 10.1097/MD.0000000000018647
8. Nakatsumi H Methicillin-resistant Staphylococcus aureus necrotizing bronchitis after radiotherapy in combination with axitinib Intern. Med. 2022 61 2931 2934 10.2169/internalmedicine.9143-21 35228430
Nakatsumi, H. et al. Methicillin-resistant Staphylococcus aureus necrotizing bronchitis after radiotherapy in combination with axitinib. Intern. Med. 61, 2931–2934 (2022).35228430 10.2169/internalmedicine.9143-21
9. Lee YH Seo H Cha SI Kim CH Lee J A case of pseudomembranous tracheitis caused by Mycoplasma pneumoniae in an immunocompetent patient Ann. Transl. Med. 2019 7 205 10.21037/atm.2019.03.70 31205923
Lee, Y. H., Seo, H., Cha, S. I., Kim, C. H. & Lee, J. A case of pseudomembranous tracheitis caused by Mycoplasma pneumoniae in an immunocompetent patient. Ann. Transl. Med. 7, 205 (2019).31205923 10.21037/atm.2019.03.70
10. Froessl LJ Abdeen Y Pseudomembranous tracheobronchitis due to mycobacterium tuberculosis Cureus 2021 13 e17173 34532194
Froessl, L. J. & Abdeen, Y. Pseudomembranous tracheobronchitis due to mycobacterium tuberculosis. Cureus 13, e17173 (2021).34532194
11. Strauss R Pseudomembranous tracheobronchitis due to Bacillus cereus Clin. Infect. Dis. 2001 33 E39 41 10.1086/322674 11486300
Strauss, R. et al. Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin. Infect. Dis. 33, E39-41 (2001).11486300 10.1086/322674
12. Khan MS Przebinda AS Claros-Sorto J Porter A Pseudomembranous tracheobronchitis: A rare presentation of: Pseudomonas aeruginosa: Infection J. Bronchol. Interv. Pulmonol. 2016 23 319 10.1097/LBR.0000000000000300
Khan, M. S., Przebinda, A. S., Claros-Sorto, J. & Porter, A. Pseudomembranous tracheobronchitis: A rare presentation of: Pseudomonas aeruginosa: Infection. J. Bronchol. Interv. Pulmonol. 23, 319 (2016).10.1097/LBR.0000000000000300
13. Gaugler C Neonatal necrotizing tracheobronchitis: Three case reports J. Perinatol. 2004 24 259 260 10.1038/sj.jp.7211041 15067297
Gaugler, C. et al. Neonatal necrotizing tracheobronchitis: Three case reports. J. Perinatol. 24, 259–260 (2004).15067297 10.1038/sj.jp.7211041
14. Yang F Lu X Acute obstructive fibrinous laryngotracheobronchitis induced by severe glyphosate surfactant intoxication: A case report World J. Emerg. Med. 2020 11 125 126 10.5847/wjem.j.1920-8642.2020.02.012 32076481
Yang, F. & Lu, X. Acute obstructive fibrinous laryngotracheobronchitis induced by severe glyphosate surfactant intoxication: A case report. World J. Emerg. Med. 11, 125–126 (2020).32076481 10.5847/wjem.j.1920-8642.2020.02.012
15. Choi HS Radiation-induced pseudomembranous tracheobronchitis: A report of two cases Thorac. Cancer 2022 13 2390 2393 10.1111/1759-7714.14561 35793785
Choi, H. S. Radiation-induced pseudomembranous tracheobronchitis: A report of two cases. Thorac. Cancer 13, 2390–2393 (2022).35793785 10.1111/1759-7714.14561
16. Kajikawa S Noda K Nozaki Y Necrotizing tracheobronchitis associated with rheumatoid arthritis Respir. Med. Case Rep. 2016 20 31 33 27896063
Kajikawa, S., Noda, K. & Nozaki, Y. Necrotizing tracheobronchitis associated with rheumatoid arthritis. Respir. Med. Case Rep. 20, 31–33 (2016).27896063
17. Fang X Cao L A case of necrotic tracheobronchitis caused by severe H1N1 combined with Staphylococcus aureus infection Zhonghua Er Ke Za Zhi 2019 57 229 231 30818904
Fang, X. & Cao, L. A case of necrotic tracheobronchitis caused by severe H1N1 combined with Staphylococcus aureus infection. Zhonghua Er Ke Za Zhi 57, 229–231 (2019).30818904
18. Park SS A case of severe pseudomembranous tracheobronchitis complicated by co-infection of influenza A (H1N1) and Staphylococcus aureus in an immunocompetent patient Tuberc. Respir. Dis. 2015 78 366 10.4046/trd.2015.78.4.366
Park, S. S. et al. A case of severe pseudomembranous tracheobronchitis complicated by co-infection of influenza A (H1N1) and Staphylococcus aureus in an immunocompetent patient. Tuberc. Respir. Dis. 78, 366 (2015).10.4046/trd.2015.78.4.366
19. Sharp JK Hereth J Fasanello J Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus Pediatr. Pulmonol. 2011 46 92 95 10.1002/ppul.21306 21171187
Sharp, J. K., Hereth, J. & Fasanello, J. Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus. Pediatr. Pulmonol. 46, 92–95 (2011).21171187 10.1002/ppul.21306
20. Tsokos M Zöllner B Feucht H-H Fatal influenza A infection with Staphylococcus aureus superinfection in a 49 year-old woman presenting as sudden death Int. J. Legal Med. 2005 119 40 43 10.1007/s00414-004-0472-1 15322829
Tsokos, M., Zöllner, B. & Feucht, H.-H. Fatal influenza A infection with Staphylococcus aureus superinfection in a 49 year-old woman presenting as sudden death. Int. J. Legal Med. 119, 40–43 (2005).15322829 10.1007/s00414-004-0472-1
21. Takahashi S Nakamura M Necrotizing tracheobronchitis caused by influenza and Staphylococcus aureus co-infection Infection 2018 46 737 739 10.1007/s15010-018-1180-y 30027437
Takahashi, S. & Nakamura, M. Necrotizing tracheobronchitis caused by influenza and Staphylococcus aureus co-infection. Infection 46, 737–739 (2018).30027437 10.1007/s15010-018-1180-y
22. Yamazaki Y Hirai K Honda T Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus Scand. J. Infect. Dis. 2002 34 211 213 10.1080/00365540110077083 12030399
Yamazaki, Y., Hirai, K. & Honda, T. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus. Scand. J. Infect. Dis. 34, 211–213 (2002).12030399 10.1080/00365540110077083
23. Gabrilovich MI Huff MD McMillen SM Quinter C Severe necrotizing tracheobronchitis from Panton–Valentine leukocidin–positive MRSA pneumonia complicating influenza A-H1N1-09 J. Bronchol. Interv. Pulmomol. 2017 24 63 66 10.1097/LBR.0000000000000314
Gabrilovich, M. I., Huff, M. D., McMillen, S. M. & Quinter, C. Severe necrotizing tracheobronchitis from Panton–Valentine leukocidin–positive MRSA pneumonia complicating influenza A-H1N1-09. J. Bronchol. Interv. Pulmomol. 24, 63–66 (2017).10.1097/LBR.0000000000000314
24. Wu X Wu L Chen Z The important role of endoscopy in management of pediatric pseudomembranous necrotizing tracheitis Front. Pediatr. 2020 8 360 10.3389/fped.2020.00360 32733826
Wu, X., Wu, L. & Chen, Z. The important role of endoscopy in management of pediatric pseudomembranous necrotizing tracheitis. Front. Pediatr. 8, 360 (2020).32733826 10.3389/fped.2020.00360
25. Bishara AJ Hittner JB Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches Psychol. Methods 2012 17 399 417 10.1037/a0028087 22563845
Bishara, A. J. & Hittner, J. B. Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches. Psychol. Methods 17, 399–417 (2012).22563845 10.1037/a0028087
26. Paget C Trottein F Mechanisms of bacterial superinfection post-influenza: A role for unconventional T cells Front. Immunol. 2019 10 336 10.3389/fimmu.2019.00336 30881357
Paget, C. & Trottein, F. Mechanisms of bacterial superinfection post-influenza: A role for unconventional T cells. Front. Immunol. 10, 336 (2019).30881357 10.3389/fimmu.2019.00336
27. Morgan M Staphylococcus aureus, Panton–Valentine leukocidin, and necrotising pneumonia BMJ 2005 331 793 794 10.1136/bmj.331.7520.793 16210260
Morgan, M. Staphylococcus aureus, Panton–Valentine leukocidin, and necrotising pneumonia. BMJ 331, 793–794 (2005).16210260 10.1136/bmj.331.7520.793
28. Yang X PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection Ann. Clin. Microbial. Antimicrob. 2023 22 103 10.1186/s12941-023-00653-4
Yang, X. et al. PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection. Ann. Clin. Microbial. Antimicrob. 22, 103 (2023).10.1186/s12941-023-00653-4
29. Zhang Y Li B Ning B Evaluating IL-6 and IL-10 as rapid diagnostic tools for gram-negative bacteria and as disease severity predictors in pediatric sepsis patients in the intensive care unit Front. Immunol. 2022 13 1043968 10.3389/fimmu.2022.1043968 36544765
Zhang, Y., Li, B. & Ning, B. Evaluating IL-6 and IL-10 as rapid diagnostic tools for gram-negative bacteria and as disease severity predictors in pediatric sepsis patients in the intensive care unit. Front. Immunol. 13, 1043968 (2022).36544765 10.3389/fimmu.2022.1043968
30. Cheng Y Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A J. Infect. Public Health 2019 12 878 883 10.1016/j.jiph.2019.05.017 31202719
Cheng, Y. et al. Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A. J. Infect. Public Health 12, 878–883 (2019).31202719 10.1016/j.jiph.2019.05.017
31. Qian F Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: A retrospective observational study BMC Infect. Dis. 2020 20 1 11 10.1186/s12879-020-05637-9
Qian, F. et al. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: A retrospective observational study. BMC Infect. Dis. 20, 1–11 (2020).10.1186/s12879-020-05637-9
32. Ma L Early peripheral blood lymphocyte subsets and cytokines in predicting the severity of influenza B virus pneumonia in children Front. Cell. Infect. Microbiol. 2023 13 1173362 10.3389/fcimb.2023.1173362 37249974
Ma, L. et al. Early peripheral blood lymphocyte subsets and cytokines in predicting the severity of influenza B virus pneumonia in children. Front. Cell. Infect. Microbiol. 13, 1173362 (2023).37249974 10.3389/fcimb.2023.1173362
33. Robinson KM Kolls JK Alcorn JF The immunology of influenza virus-associated bacterial pneumonia Curr. Opin. Immunol. 2015 34 59 10.1016/j.coi.2015.02.002 25723597
Robinson, K. M., Kolls, J. K. & Alcorn, J. F. The immunology of influenza virus-associated bacterial pneumonia. Curr. Opin. Immunol. 34, 59 (2015).25723597 10.1016/j.coi.2015.02.002
34. Wang S Yang J Sun W Tao Y Severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus co-infection in an immunocompetent patient Ann. Clin. Microbiol. Antimicrob. 2024 23 55 10.1186/s12941-024-00715-1 38886754
Wang, S., Yang, J., Sun, W. & Tao, Y. Severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus co-infection in an immunocompetent patient. Ann. Clin. Microbiol. Antimicrob. 23, 55 (2024).38886754 10.1186/s12941-024-00715-1
35. Pan P Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19 Virol. J. 2022 19 57 10.1186/s12985-022-01786-2 35346253
Pan, P. et al. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19. Virol. J. 19, 57 (2022).35346253 10.1186/s12985-022-01786-2
36. Luporini RL IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19 Cytokine 2021 143 155507 10.1016/j.cyto.2021.155507 33839002
Luporini, R. L. et al. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19. Cytokine 143, 155507 (2021).33839002 10.1016/j.cyto.2021.155507
37. Hamade B Huang DT Procalcitonin: Where are we now? Crit. Care Clin. 2020 36 23 40 10.1016/j.ccc.2019.08.003 31733680
Hamade, B. & Huang, D. T. Procalcitonin: Where are we now?. Crit. Care Clin. 36, 23–40 (2020).31733680 10.1016/j.ccc.2019.08.003
38. Richards O Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS Antibiotics 2021 10 1425 10.3390/antibiotics10111425 34827363
Richards, O. et al. Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS. Antibiotics 10, 1425 (2021).34827363 10.3390/antibiotics10111425
39. Guarracino F Bertini P Pinsky MR Cardiovascular determinants of resuscitation from sepsis and septic shock Crit. Care 2019 23 118 10.1186/s13054-019-2414-9 30987647
Guarracino, F., Bertini, P. & Pinsky, M. R. Cardiovascular determinants of resuscitation from sepsis and septic shock. Crit. Care 23, 118 (2019).30987647 10.1186/s13054-019-2414-9
40. Wheeler DS Jeffries HE Zimmerman JJ Wong HR Carcillo JA Sepsis in the pediatric cardiac intensive care unit World J. Pediatr. Congenit. Heart Surg. 2011 2 393 399 10.1177/2150135111403781 22337571
Wheeler, D. S., Jeffries, H. E., Zimmerman, J. J., Wong, H. R. & Carcillo, J. A. Sepsis in the pediatric cardiac intensive care unit. World J. Pediatr. Congenit. Heart Surg. 2, 393–399 (2011).22337571 10.1177/2150135111403781
41. Koch E Lovett S Nghiem T Riggs RA Rech MA Shock index in the emergency department: Utility and limitations Open Access Emerg. Med. 2019 11 179 199 10.2147/OAEM.S178358 31616192
Koch, E., Lovett, S., Nghiem, T., Riggs, R. A. & Rech, M. A. Shock index in the emergency department: Utility and limitations. Open Access Emerg. Med. 11, 179–199 (2019).31616192 10.2147/OAEM.S178358
42. Fang W-F Incorporation of dynamic segmented neutrophil-to-monocyte ratio with leukocyte count for sepsis risk stratification Sci. Rep. 2019 9 19756 10.1038/s41598-019-56368-0 31875017
Fang, W.-F. et al. Incorporation of dynamic segmented neutrophil-to-monocyte ratio with leukocyte count for sepsis risk stratification. Sci. Rep. 9, 19756 (2019).31875017 10.1038/s41598-019-56368-0
43. Zhu B Correlation between white blood cell count at admission and mortality in COVID-19 patients: A retrospective study BMC Infect. Dis. 2021 21 574 10.1186/s12879-021-06277-3 34126954
Zhu, B. et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: A retrospective study. BMC Infect. Dis. 21, 574 (2021).34126954 10.1186/s12879-021-06277-3
44. Currie GP Alluri R Christie GL Legge JS Pneumothorax: An update Postgrad. Med. J. 2007 83 461 465 10.1136/pgmj.2007.056978 17621614
Currie, G. P., Alluri, R., Christie, G. L. & Legge, J. S. Pneumothorax: An update. Postgrad. Med. J. 83, 461–465 (2007).17621614 10.1136/pgmj.2007.056978
